Dr. Evan Sickle Cell Foundation

18/06/2025

🩸 WORLD SICKLE CELL DAY | JUNE 19
🌍 Brought to you by Dr. Evan Sickle Cell Foundation

🧬 Sickle Cell is not a curse. It’s not a weakness. It’s a condition – and warriors fight daily battles many will never understand.
Today, we raise our voices for the heroes among us – especially the children and families we walk with.

💥 Let’s break the chains of ignorance, fear, and stigma.
💪🏾 Let’s amplify strength, celebrate perseverance, and bring hope to every warrior.

📌 KNOW your genotype
📌 SUPPORT a warrior
📌 SPEAK against stigma
📌 PRAY and ACT with compassion

🟣 Unchained Minds exists to unlock awareness, support warrior families, and build a future where SCD does not limit dreams.

🧠 FREEDOM. STRENGTH. PERSEVERANCE.


.EvanSickleCellFoundation




🔗 Let’s unchain minds together.

09/12/2024

UNDERSTANDING SICKLE CELL DISEASE

Episode 17

History of Crisis in Sickle Cell Carriers

The history of sickle cell disease (SCD) and its crises has been shaped by a combination of genetic discovery, cultural understanding, and medical advancements. While sickle cell crises are predominantly associated with individuals who inherit two copies of the sickle cell gene, carriers (those with only one copy) have also faced unique challenges under certain conditions. Here is a breakdown of the history and context behind crises in sickle cell carriers:

---

1. Discovery of Sickle Cell Disease and Trait

1910: The first documented case of sickle cell anemia was described by Dr. James Herrick, who identified the sickle-shaped red blood cells in a dental student from Grenada.

1949: Linus Pauling and his colleagues identified sickle cell disease as the first "molecular disease," linking it to an abnormality in hemoglobin.

1950s: Studies began differentiating between those with sickle cell disease (two abnormal genes) and sickle cell trait (one abnormal gene). Initially, carriers were believed to be asymptomatic.

---

2. Crises in Carriers Under Specific Conditions

Initially, it was thought that sickle cell carriers did not experience complications. However, historical records and medical reports began to challenge this notion:

High Altitude Incidents (1960s):
Reports emerged of carriers experiencing mild symptoms of sickling at high altitudes due to lower oxygen levels. Soldiers stationed in mountainous areas or pilots flying unpressurized planes were among the first groups to report such issues.

Exertional Deaths in Athletes (1970s):
During this period, there were cases of sudden death among African-American athletes with sickle cell trait. These incidents were linked to intense physical activity, dehydration, and heat stress, which triggered exertional sickling and vaso-occlusion.

Malaria Protection and Anemia (Evolutionary Context):
Sickle cell carriers were found to have a genetic advantage against malaria, a discovery that helped explain why the gene persisted in regions like sub-Saharan Africa. However, during severe infections or malnutrition, carriers could still experience complications such as anemia.

---

3. Key Historical Examples

Military Reports (1970s-1980s):
In the U.S. military, cases of sudden exertional collapse among recruits with sickle cell trait led to changes in physical training protocols and awareness campaigns. These incidents were crucial in understanding the potential for crises in carriers under stress.

The NCAA Case Studies (1990s):
The National Collegiate Athletic Association (NCAA) began tracking exertional deaths in athletes. This led to mandatory screening for sickle cell trait in college athletes to prevent such crises during training.

---

4. Scientific Milestones

1990s: Research confirmed that carriers could experience complications such as splenic infarcts (tissue death in the spleen) during high-altitude travel, further proving that the condition was not always benign.

2000s: Advances in imaging and biomarker studies allowed for better diagnosis and management of silent ischemia (restricted blood flow), even in carriers.

---

5. Social and Medical Implications

Stigma and Misunderstanding:
Historically, sickle cell trait and disease were poorly understood, leading to stigma in communities. In some African societies, families with carriers or affected individuals were shunned, as the condition was misattributed to curses or poor ancestry.

Advocacy and Awareness (1970s-Present):
Organizations like the Sickle Cell Society and Sickle Cell Disease Association of America worked to dispel myths and advocate for better medical understanding. Campaigns began educating carriers about the risks of extreme exertion, dehydration, and high-altitude exposure.

---

6. Modern Context

Today, medical science has made significant strides in understanding sickle cell crises in carriers. While these crises are rare compared to those in individuals with sickle cell disease, carriers remain at risk under specific circumstances such as:

Extreme physical exertion

Severe dehydration

Low oxygen environments (e.g., high altitudes or unpressurized flights)

---

The history of sickle cell crises among carriers reflects an evolving understanding of how even a single gene mutation can influence health, especially under environmental or physiological stressors. This progression has shaped modern management strategies and highlighted the need for continued research and education.

29/11/2024

*SICKLE CELL DISEASE: KENYA'S GENETIC STRUGGLE*

By Wekesa E.N.

Sickle cell disease (SCD) has a deep historical and genetic roots, especially in regions like sub-Saharan Africa, including Kenya. This inherited blood disorder, caused by mutations in the hemoglobin gene, emerged as an evolutionary response to malaria. Carriers of the sickle cell trait (HbAS) were found to have a survival advantage against malaria, particularly in regions where the disease was endemic. Over generations, this genetic adaptation became prevalent in malaria-endemic areas, making sickle cell disease more common in such populations.

"As a sickle cell carrier, the last time I was diagnosed of malaria was 5 years ago", recalled Ariana,a caregiver (not her real name)

"Sickle cell carriers have a fetal hemoglobin that fights against malaria and makes them resistant to it", said Dr. Obura Elvis an oncological pharmacist at Moi Teaching and Referral Hospital

In Kenya, SCD affects approximately 1 in 10 people in certain regions, especially in the western and coastal parts of the country. These areas overlap with zones historically affected by malaria, highlighting the genetic link.

"Sickle cell cases are common in the western and coastal regions of Kenya, since they are malaria prone areas", said Peter Ahago during a sickle cell training at Baraka health center with sickle cell warriors and caregivers

The prevalence of SCD comes with significant health challenges. Children born with the disease face a high risk of severe complications, including anemia, organ damage, and recurrent pain episodes. Without timely diagnosis and treatment, many do not survive past childhood.

"Some common complications of sickle cell include stroke, vision loss, acute chest syndrome,spleenic sequential,AVN and leg ulcers. These complications might be life threatening if not handled early ", added Ahago

The current state of SCD care in Kenya is improving but remains constrained by limited resources. Access to specialized treatment, such as hydroxyurea therapy and bone marrow transplants, is still out of reach for many. The government and organizations like the Ministry of Health and Kenya Haemophilia and Thrombosis Association have prioritized newborn screening and public awareness campaigns to reduce the burden of the disease. Recent partnerships with global health organizations aim to expand these programs.

"The government should work with speed on the implementation of SHIF and include the sickle cell clinic funding under the SHA funding to help lighten the burden of the costs of managing SCD", said Kiplagat a caregiver during a conversation during the SCD clinic at MTRH

However, more is needed to fully address the challenges. “Sickle cell disease is a silent epidemic in Kenya,” notes Dr. Jane Githinji, a hematologist at Kenyatta National Hospital. “We need comprehensive care programs that include early screening, regular follow-ups, and community education.”

Globally, innovations such as gene therapy are showing promise in treating SCD, though they are still expensive and inaccessible in Kenya. Local efforts focus on improving palliative care and ensuring essential medicines like folic acid and pain management drugs are available. The WHO notes that coordinated management and prevention programs could significantly reduce the health burden of SCD in Africa, including Kenya.

Kenya’s fight against sickle cell disease is ongoing, with a need for increased investment in healthcare infrastructure and research. As public awareness grows, so does hope for better outcomes for those living with this challenging condition.

29/11/2024

UNDERSTANDING SICKLE CELL

Episode 16

Complications of sickle cell

Sickle cell disease (SCD) is a genetic blood disorder that can cause various complications due to the abnormal shape of red blood cells, which can block blood flow and damage organs. Below are the common complications of SCD:

1. Acute Pain (Sickle Cell Crisis)

Caused by the blockage of blood flow in small blood vessels.

Pain can occur in the chest, abdomen, joints, or bones and vary in intensity.

2. Anemia

Due to the rapid breakdown of sickle-shaped cells, leading to fatigue, weakness, and pallor.

3. Infections

Increased susceptibility due to spleen damage (asplenia or functional hyposplenism).

Common infections: pneumonia, meningitis, and septicemia.

4. Hand-Foot Syndrome (Dactylitis)

Painful swelling of the hands and feet caused by blocked blood flow in small bones, often seen in children.

5. Stroke

Blood vessel blockage or rupture in the brain, causing neurological deficits, particularly in children with SCD.

6. Acute Chest Syndrome

Life-threatening condition involving chest pain, fever, difficulty breathing, and pulmonary infiltrates on X-ray.

7. Delayed Growth and Puberty

Caused by chronic anemia and nutrient deficiency.

8. Vision Problems (Retinopathy)

Blocked blood vessels in the eye can lead to retinal damage and vision loss.

9. Gallstones

Caused by excess bilirubin from the breakdown of red blood cells, leading to gallstone formation.

10. Leg Ulcers

Slow-healing sores, particularly around the ankles, due to poor blood flow.

11. Priapism

Painful, prolonged erections caused by blocked blood flow in the p***s, potentially leading to impotence if untreated.

12. Organ Damage

Chronic damage to organs such as the spleen, liver, kidneys, and lungs due to lack of oxygen.

Kidney complications can include hematuria and kidney failure.

13. Bone Problems

Avascular necrosis (especially in hips and shoulders) due to lack of blood flow to the bones.

14. Mental Health Issues

Chronic pain and illness can lead to depression, anxiety, and stress.

15. Pregnancy Complications

Increased risk of miscarriage, preterm labor, low birth weight, and preeclampsia in women with SCD.

Prevention and Management

Regular medical care and proactive treatments like hydroxyurea, blood transfusions, and bone marrow transplants can reduce complications.

Vaccinations and antibiotics to prevent infections.

Healthy lifestyle choices, including hydration, a balanced diet, and regular exercise.

Managing sickle cell disease requires a multidisciplinary approach to address these potential complications effectively.

28/10/2024

UNDERSTANDING SICKLE CELL

Episode 15

Uses and importance of Hydroxyurea and folic acid in sickle cell

Hydroxyurea and folic acid play essential roles in the management of sickle cell disease (SCD) by helping to alleviate symptoms, reduce complications, and improve overall quality of life.

Hydroxyurea

Hydroxyurea is a medication widely used to manage sickle cell disease, particularly for individuals who experience frequent painful episodes and complications associated with the disease. Its key benefits include:

1. Increasing Fetal Hemoglobin (HbF) Levels: Hydroxyurea stimulates the production of fetal hemoglobin, which helps reduce the sickling of red blood cells. Higher levels of HbF lower the frequency of pain crises and decrease the risk of blood vessel blockages.

2. Reducing Painful Crises: By preventing red blood cell sickling, hydroxyurea minimizes the episodes of severe pain (also called vaso-occlusive crises) that characterize SCD.

3. Decreasing Hospitalizations: Fewer pain crises and complications mean that individuals on hydroxyurea often require fewer hospital visits and interventions, leading to an improved quality of life.

4. Improving Red Blood Cell Health: Hydroxyurea helps increase the size and flexibility of red blood cells, making them less prone to breaking apart (hemolysis), which can lead to anemia and other complications.

Folic Acid

Folic acid is a B-vitamin essential for the production and repair of red blood cells. For individuals with SCD, folic acid is crucial because:

1. Supporting Red Blood Cell Production: SCD patients often have hemolytic anemia due to the rapid breakdown of red blood cells. Folic acid is vital for red blood cell production and helps combat anemia.

2. Promoting Cell Repair and Growth: Folic acid aids in DNA synthesis and cellular repair, which is essential for individuals with SCD, as they experience high red blood cell turnover.

3. Preventing Deficiencies: The body’s increased need for folic acid in SCD patients means they are at higher risk of deficiency. Supplementing with folic acid helps prevent complications like fatigue and developmental delays, which can be worsened by anemia.

Importance of Hydroxyurea and Folic Acid Combination

Together, hydroxyurea and folic acid support effective management of SCD by reducing the frequency and severity of pain episodes, preventing anemia, and improving the overall health of red blood cells. This combination enhances life quality and reduces the risk of severe complications such as stroke, organ damage, and infections, common among SCD patients.

Follow Dr. Evan Sickle Cell Foundation Senater Nelly

11/10/2024

UNDERSTANDING SICKLE CELL

Episode 14

Understanding misconceptions and overcoming stigma in sickle cell

Misconceptions about sickle cell disease (SCD) can contribute to the stigma faced by those living with the condition. Common misconceptions and ways to break them include:

1. Sickle cell is contagious: Many people wrongly believe that SCD can be spread through physical contact or close interaction. This is false, as SCD is a genetic disorder inherited from both parents. Education about its hereditary nature can dispel this myth, highlighting that it’s not infectious.

2. Only people of African descent have sickle cell: While SCD is more common among people of African descent, it can affect individuals from other ethnic backgrounds, such as those of Hispanic, Middle Eastern, and Indian descent. Raising awareness of this fact helps fight the narrative that it’s exclusive to one race.

3. People with sickle cell can't live normal lives: There’s a misconception that those with SCD are incapable of leading full, productive lives. In reality, with proper medical care, many individuals with SCD can manage their condition, pursue careers, and live fulfilling lives. Sharing success stories of people living with SCD can challenge this belief.

4. Sickle cell patients are addicted to pain medication: Chronic pain is a significant symptom of SCD, leading many to require frequent pain management. However, this doesn’t mean that patients are addicted to medications. Educating healthcare providers and the public about the nature of sickle cell pain can help reduce judgment toward patients seeking care.

5. Sickle cell always leads to early death: While SCD can cause severe health complications, advancements in medical care have improved life expectancy significantly. Breaking this misconception requires highlighting the importance of early intervention, routine care, and medical advancements that have enhanced quality of life for many patients.

Breaking the Stigma

Education campaigns: The most effective way to fight stigma is through widespread education. Schools, communities, and healthcare centers can host awareness programs about SCD to dispel myths and promote understanding.

Patient advocacy: Encouraging individuals living with SCD to share their stories can humanize the condition and show that people with SCD are just like anyone else. Creating platforms for advocacy and support groups also allows for open conversations and increased visibility.

Improving healthcare provider awareness: Training healthcare workers on SCD’s symptoms and treatment protocols can reduce bias and improve the care and empathy patients receive.

Media representation: Ensuring accurate portrayals of SCD in the media can challenge existing stereotypes. Positive and realistic portrayals help the public view SCD patients through a more compassionate lens.

By addressing misconceptions and actively promoting empathy and understanding, we can reduce the stigma associated with sickle cell and create a more supportive environment for those affected. Photo credits to owners.

follow Dr. Evan Sickle Cell Foundation Senater Nelly for the next educative episode on sickle cell

10/10/2024

UNDERSTANDING SICKLE CELL
Episode 13

IMPORTANT INFORMATION TO KNOW ABOUT SICKLE CELL AND WHY

Sickle cell disease (SCD) is a genetic blood disorder that primarily affects the red blood cells, causing them to form an abnormal crescent or "sickle" shape. Here’s the relevant information about sickle cell that one needs to equip themselves with:

1. Genetic Nature and Inheritance:

What it is: SCD is inherited when a child receives two sickle cell genes, one from each parent.

Why it matters: Understanding inheritance patterns helps with family planning, especially if both partners carry the sickle cell trait. Carriers (with only one sickle cell gene) generally do not show symptoms but can pass the trait to their children.

2. Symptoms:

What they are: Symptoms of SCD include episodes of pain (crises), anemia, fatigue, swelling in hands and feet, frequent infections, delayed growth, and vision problems.

Why it matters: Recognizing the signs early on helps in managing pain and preventing complications. Individuals with SCD need to avoid situations that could trigger pain crises, such as dehydration, stress, and extreme temperatures.

3. Complications:

What they are: SCD can lead to serious complications like stroke, acute chest syndrome, organ damage, pulmonary hypertension, and infection due to a weakened immune system.

Why it matters: Awareness of potential complications allows individuals and caregivers to take preventive measures, monitor health closely, and seek early treatment to avoid life-threatening situations.

4. Management and Treatment:

What it includes: Treatment options include pain management, hydration, blood transfusions, and medications like hydroxyurea. In some cases, bone marrow transplants may offer a potential cure.

Why it matters: Proper treatment helps manage symptoms, reduce pain crises, and prevent complications, improving the quality of life for people living with SCD.

5. Preventive Measures and Lifestyle Adjustments:

What they are: Maintaining hydration, avoiding extreme temperatures, reducing stress, and taking preventive vaccinations are crucial to managing the disease.

Why it matters: Lifestyle modifications help reduce the frequency of pain crises and infections, improving overall health and preventing long-term complications.

6. Importance of Regular Medical Care:

What it involves: Regular check-ups, screenings for complications, and preventive treatments like vaccines (especially for infections such as pneumonia and meningitis) are critical for managing SCD.

Why it matters: Consistent medical care helps monitor and address any emerging issues early, potentially preventing severe complications.

7. Community and Emotional Support:

What it entails: Joining support groups, receiving counseling, and having a strong support system from family and friends can be beneficial for those affected.

Why it matters: Emotional and social support improves mental health, helping individuals and their families cope with the challenges of living with SCD.

By equipping oneself with this knowledge, individuals with SCD and their caregivers can take proactive steps to manage the disease and prevent severe health complications, ensuring better quality of life.

follow Dr. Evan Sickle Cell Foundation and Senater Nelly

08/10/2024

08/10/2024

UNDERSTANDING SICKLE CELL

Episode 12

IMPORTANCE OF SICKLE CELL SUPPORT GROUPS AND EVENTS

Participating in local sickle cell events and groups is vital for several reasons:

1. Community Support: Individuals with sickle cell disease and their families often face unique challenges, both physically and emotionally. Local events provide an opportunity to connect with others who understand these struggles, offering support, empathy, and encouragement. These groups foster a sense of belonging and reduce the isolation many individuals feel.

2. Awareness and Education: Participation in these events helps raise awareness about sickle cell disease. This is crucial for educating the public, healthcare professionals, and policymakers about the condition, the need for better healthcare access, and funding for research. Awareness campaigns can dispel myths and inform people about preventive measures, symptoms, and treatment options.

3. Advocacy and Policy Change: Local groups often serve as platforms for advocacy, where individuals can unite to push for policy changes, better healthcare facilities, and more comprehensive sickle cell disease programs. Collective voices can have a significant impact on gaining attention from legislators and stakeholders.

4. Access to Resources and Information: Events and support groups often provide valuable information about treatment options, clinical trials, and advances in research. For individuals affected by sickle cell, these events offer opportunities to meet medical professionals, discover new care methods, and stay updated on the latest developments.

5. Empowerment: Engaging with local groups empowers patients and their families to take an active role in managing their health. It can inspire individuals to share their experiences, raise funds, and organize their own events, contributing to the larger cause of fighting sickle cell disease.

In sum, local sickle cell events and groups provide emotional support, raise awareness, advocate for better care, and connect individuals to crucial resources—all of which can improve quality of life

follow this sickle cell support group Dr. Evan Sickle Cell Foundation and Senater Nelly

Photo credits to owners

07/10/2024